Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Denosumab Raises Hypocalcemia Risk in Chronic Kidney Disease
TOPLINE: Denosumab treatment for osteoporosis raises the risk for hypocalcemia, which worsens with advancing stages of chronic kidney disease (CKD), in those with CKD–Mineral and Bone Disorder (CKD-MBD) and in those undergoing dialysis. METHODOLOGY: There is a paucity of data…
English